CTRI/2018/01/011587已完成未知
Effectiveness and acceptability of aqueous cinnamon extract mouthrinse in maintaining salivary and tongue coating pH in comparison with the gold standard: a randomized controlled trial
Aditi Hegde0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Persons volunteering for participation and willing to provide informed consent.
排除标准
- •Persons who have received antimicrobial therapy in the past two weeks and those using orthodontic or prosthetic appliances.
研究者
相似试验
尚未招募
3 期
Analysis of the effectiveness of cinnamon in the reduction of sugar and fat levels of adults with type 2 DiabetesC18.452.394.750.149Type 2 Diabetes MellitusRBR-2kkb6dniversidade Federal do Ceará
尚未招募
2 期
Evaluation of the effect of plant compounds extract (including aqueous extract of Ador-Cancer, saffron petals and mountain tea) in patients with coronary diseasesymptoms of COVID-19 patients.COVID-19, virus identifiedU07.1IRCT20211108053002N1Rafsanjan University of Medical Sciences40
招募中
3 期
The effect ofTribulus on kidney stoneskidney stone.IRCT20240513061783N1Birjand University of Medical Sciences40
进行中（未招募）
不适用
Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with inner ear vertigo.Vertigo of peripheral originMedDRA version: 15.0Level: LLTClassification code 10031615Term: Other and unspecified peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 14.1Level: LLTClassification code 10058708Term: Rotatory vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 14.1Level: PTClassification code 10047344Term: Vertigo labyrinthineSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 14.1Level: LLTClassification code 10034641Term: Peripheral vertigo, unspecifiedSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 15.0Level: LLTClassification code 10032379Term: Other peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-004025-27-ATHENNIG ARZNEIMITTEL GmbH & Co. KG224
进行中（未招募）
1 期
Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with inner ear vertigo.Vertigo of peripheral originMedDRA version: 16.1Level: LLTClassification code 10031615Term: Other and unspecified peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: LLTClassification code 10058708Term: Rotatory vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: PTClassification code 10047344Term: Vertigo labyrinthineSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: LLTClassification code 10034641Term: Peripheral vertigo, unspecifiedSystem Organ Class: 10013993 - Ear and labyrinth disordersMedDRA version: 16.1Level: LLTClassification code 10032379Term: Other peripheral vertigoSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-004025-27-BGHENNIG ARZNEIMITTEL GmbH & Co. KG224